A phase III randomized study comparing perioperative nivolumab vs. observation in patients with localized renal cell carcinoma undergoing nephrectomy (PROSPER RCC). Background: Antiangiogenic agents, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results